Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine
(NASDAQ: PRAX) Delayed: 352.48 +0.67 (0.19%)
Previous Close $351.81    52 Week High $ 
Open $342.25    52 Week Low $ 
Day High $356.29    P/E N/A 
Day Low $339.50    EPS $ 
Volume 252,618